Orhan Korkmaz, MD, PhD
Postdoctoral Fellow
Boston University School of Medicine
Dept of Anatomy & Neurobiology




Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Öncü Kaya EM, Korkmaz OT, Yeniceli Ugur D, Sener E, Tunçel AN, Tunçel M. Determination of Ochratoxin-A in the brain microdialysates and plasma of awake, freely moving rats using ultra high performance liquid chromatography fluorescence detection method. J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Sep 01; 1125:121700. PMID: 31302476
     
  2. Korkmaz OT, Ay H, Aytan N, Carreras I, Kowall NW, Dedeoglu A, Tuncel N. Vasoactive Intestinal Peptide Decreases ß-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer's Disease. J Mol Neurosci. 2019 Jul; 68(3):389-396.View Related Profiles. PMID: 30498985
     
  3. Korkmaz OT, Tunçel N. Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson's Disease. Curr Pharm Des. 2018; 24(39):4693-4701. PMID: 30636594
     
  4. Yelkenli IH, Ulupinar E, Korkmaz OT, Sener E, Kus G, Filiz Z, Tunçel N. Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats. J Mol Neurosci. 2016 Jun; 59(2):280-9. PMID: 27115671; DOI: 10.1007/s12031-016-0757-0;
     
  5. Korkmaz OT, Aytan N, Carreras I, Choi JK, Kowall NW, Jenkins BG, Dedeoglu A. 7,8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis. Neurosci Lett. 2014 Apr 30; 566:286-91.View Related Profiles. PMID: 24637017; DOI: 10.1016/j.neulet.2014.02.058;
     
  6. Korkmaz O, Ay H, Ulupinar E, Tunçel N. Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats. J Mol Neurosci. 2012 Nov; 48(3):565-73. PMID: 22544516
     
  7. Tunçel N, Korkmaz OT, Tekin N, Sener E, Akyüz F, Inal M. Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum. J Mol Neurosci. 2012 Jan; 46(1):51-7. PMID: 21850490
     
  8. Yeniceli D, Sener E, Korkmaz OT, Dogrukol-Ak D, Tuncel N. A simple and sensitive LC-ESI-MS (ion trap) method for the determination of bupropion and its major metabolite, hydroxybupropion in rat plasma and brain microdialysates. Talanta. 2011 Mar 15; 84(1):19-26. PMID: 21315892
     
  9. Korkmaz OT, Tunçel N, Tunçel M, Oncü EM, Sahintürk V, Celik M. Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF) by mast cells. J Mol Neurosci. 2010 Jun; 41(2):278-87. PMID: 19953344
     
  10. Tore F, Korkmaz OT, Dogrukol-Ak D, Tunçel N. The effects of vasoactive intestinal peptide on dura mater nitric oxide levels and vessel-contraction responses in sympathectomized rats. J Mol Neurosci. 2010 Jun; 41(2):288-93. PMID: 19936638
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 10 publications over 8 distinct years, with a maximum of 2 publications in 2009 and 2018

YearPublications
20092
20101
20111
20121
20141
20161
20182
20191

Contact for Mentoring:

Korkmaz's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department